Characteristics of Episodic Ataxia Syndrome

• Register: ClinicalTrials.gov
• Last refreshed on: 17 October 2012
• Main ID: NCT00266760
• Date of registration: 16/12/2005
• Primary sponsor: Office of Rare Diseases (ORD)
• Public title: Characteristics of Episodic Ataxia Syndrome
• Scientific title: Episodic Ataxia Syndrome: Genotype-phenotype Correlation and Longitudinal Study
• Date of first enrolment: May 2006
• Target sample size: 125
• Recruitment status: Active, not recruiting
• URL: http://clinicaltrials.gov/show/NCT00266760
• Study type: Observational
• Study design: Observational Model: Cohort, Time Perspective: Prospective

Countries of recruitment

Canada, United Kingdom, United States

Contacts

• Name: Tracey Graves, MD
• Affiliation: Institute of Neurology and National Hospital for Neurology

• Name: Joanna C. Jen, MD, PhD
• Affiliation: University of California, Los Angeles

• Name: Robert W. Baloh, MD
• Affiliation: University of California, Los Angeles

• Name: Yoon-Hee Cha, MD
• Affiliation: University of California, Los Angeles

Key inclusion & exclusion criteria

Inclusion Criteria:

- A clinically confirmed diagnosis of episodic ataxia as defined by one of the
following three features:

1. Clear-cut episodes of recurrent, transient ataxia

2. Mutation confirmed in KCNA1 or CACNA1A

3. Ataxic features with a first degree relative with episodic ataxia

Exclusion Criteria:

- Any other disorder known to cause episodic ataxia



Age minimum: 5 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Cerebellar Diseases

Episodic Ataxia Syndrome

Secondary ID(s)

RDCRN 5302

U54RR19482-03

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Rare Diseases Clinical Research Network